M. Matchett

发表

Development of 1H-Pyrazolo[3,4-b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.

M. D. Hill, J. Macor, T. Molski, 2016, ACS medicinal chemistry letters.

Design of an Automated Enhanced-Throughput Platform for Functional Characterization of Positive Allosteric Modulator-Induced Leftward Shifts in Apparent Agonist Potency In Vitro

John Watson, A. Hendricson, Ronald J. Knox, 2012, Journal of laboratory automation.

Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation

J. Krause, M. E. Buck, Weifeng Yu, 2008, Journal of Pharmacology and Experimental Therapeutics.

The P2X 3 Antagonist P 1 , P 5 -Di[inosine-5 (cid:1) ] Pentaphosphate Binds to the Desensitized State of the Receptor in Rat Dorsal Root Ganglion Neurons

J. Krause, Weifeng Yu, M. Matchett, 2005 .

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain.

N. Meanwell, J. Herrington, D. Post‐Munson, 2018, Journal of medicinal chemistry.

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5.

J. Macor, Amy Easton, Anand Balakrishnan, 2016, ACS medicinal chemistry letters.

Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box.

J. Macor, Amy Easton, Anand Balakrishnan, 2016, Bioorganic & medicinal chemistry letters.

Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation.

Andrea Mcclure, Ping Chen, N. Meanwell, 2017, Bioorganic & medicinal chemistry.

The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.

D. L. Abbott, R. Wolff, W. Hoffman, 1996, The Journal of pharmacology and experimental therapeutics.

Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain.

N. Meanwell, J. Herrington, D. Post‐Munson, 2017, Journal of medicinal chemistry.

Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors.

N. Meanwell, J. Herrington, R. Pieschl, 2019, Bioorganic & medicinal chemistry letters.

Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors.

Andrea Mcclure, N. Meanwell, J. Herrington, 2018, Bioorganic & Medicinal Chemistry Letters.

Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain.

N. Meanwell, J. Herrington, D. Post‐Munson, 2017, Journal of medicinal chemistry.